Login

Exclusive interview with Larry Ellison, CEO of Oracle Corp, discussing the future of technology and business strategies. 00:10:00

Share On Facebook Share On Twitter

Oracle Japan's CEO is Toshimitsu Misawa, 

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Thierry Fautier, VP of Video Strategy at Harmonic Inc., shares comments on the company's video strategy.
00:10:00
The 5 Most Common Financial Mistakes to Avoid | Lori Bodenhamer - Financial Planner of Abundo Wealth
00:10:00
Navigating the Investment Banking Hiring Landscape: Challenges and Opportunities
00:10:00
Black Earth Minerals: A Promising Graphite Project in Madagascar
00:10:00
Diversifying for Long-Term Growth: Gerard O’Reilly on Opportunities Beyond the Magnificent 7 | Gerard O'Reilly - Co-CEO & CIO, Dimensional Fund Advisors
00:10:00
Mastering Income Generation at City of London Investment Trust
00:10:00
Antony Beckmand Highlights Major Boost from Middagshvile Drilling and Sulphide Discoveries | Antony Beckmand , CEO, Kuniko Limited.
00:10:00
Tim's Lasting Lessons: Insights from the Founder of Johnson Investment Counsel
00:10:00
Atac Resources: Pioneering Carlin-Style Gold Discoveries Outside Nevada in Canada's Yukon
00:10:00
Mr. David Sin is the Co-Founder, Group President, and Deputy Chairman of the Board of Fullerton Health, and an alumnus of The Chinese High School.
00:10:00
India's Castor Oil Industry: Global Demand, Production, and Market Leadership|Mr. Abhay V. Udeshi, Chairman, Jayant Agro-Organics Ltd.
00:10:00
we are focused on redefining the treatment of spinal cord injury|Richard Toselli,MD,InVivo Therapeutics Holdings Corp

© 2026 Nehu